Technology
VenoStent has a new technology to improve outcomes for dialysis patients – Yahoo Lifestyle Australia
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients. Failed dialysis surgeries occur …
Timothy Bouré and his co-founder Geoffrey Lucks were both near broke when they moved to Dallas to join the first accelerator they entered after forming VenoStent, a company that aims to improve outcomes for dialysis patients.
Failed dialysis surgeries occur in roughly 55% to 65% of patients with end-stage renal disease, according to the company. Caring for these patients can cost the Medicare and Medicaid Services system roughly $2 billion per year — and Bouré and Lucks believed that they’d co…
-
General12 hours agoAnne-Marie Te Whiu on new book of poetry, Mettle, and why she dedicated it to her younger self
-
General10 hours agoNestle fires CEO after relationship with employee
-
Noosa News13 hours agoJazz sellout at The J
-
Noosa News12 hours agoAustralia’s winter warmer than predicted, but were temperatures actually below average?